Systematic review and meta-analysis find prognostic value of lymphocyte-to-monocyte ratio for survival in breast cancer patients, suggesting further research is needed.
This meta-analysis identified the prognostic value of LMR for OS and DFS in breast cancer. However, selection bias existed due to the predominance of retrospective studies, and considerable heterogeneity was observed for some indicators. Further research is necessary to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: